rs373462792
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016239.4(MYO15A):c.8767C>A(p.Arg2923Arg) variant causes a synonymous change. The variant allele was found at a frequency of 0.00000756 in 1,455,986 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000076 ( 0 hom. )
Consequence
MYO15A
NM_016239.4 synonymous
NM_016239.4 synonymous
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 4.38
Genes affected
MYO15A (HGNC:7594): (myosin XVA) This gene encodes an unconventional myosin. This protein differs from other myosins in that it has a long N-terminal extension preceding the conserved motor domain. Studies in mice suggest that this protein is necessary for actin organization in the hair cells of the cochlea. Mutations in this gene have been associated with profound, congenital, neurosensory, nonsyndromal deafness. This gene is located within the Smith-Magenis syndrome region on chromosome 17. Read-through transcripts containing an upstream gene and this gene have been identified, but they are not thought to encode a fusion protein. Several alternatively spliced transcript variants have been described, but their full length sequences have not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO15A | NM_016239.4 | c.8767C>A | p.Arg2923Arg | synonymous_variant | Exon 50 of 66 | ENST00000647165.2 | NP_057323.3 | |
MYO15A | XM_017024715.3 | c.8770C>A | p.Arg2924Arg | synonymous_variant | Exon 48 of 64 | XP_016880204.1 | ||
MYO15A | XM_017024714.3 | c.8707C>A | p.Arg2903Arg | synonymous_variant | Exon 47 of 63 | XP_016880203.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 0.00000756 AC: 11AN: 1455986Hom.: 0 Cov.: 32 AF XY: 0.00000691 AC XY: 5AN XY: 723756 show subpopulations
GnomAD4 exome
AF:
AC:
11
AN:
1455986
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
723756
Gnomad4 AFR exome
AF:
AC:
0
AN:
33298
Gnomad4 AMR exome
AF:
AC:
0
AN:
44092
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26000
Gnomad4 EAS exome
AF:
AC:
0
AN:
39354
Gnomad4 SAS exome
AF:
AC:
0
AN:
85218
Gnomad4 FIN exome
AF:
AC:
0
AN:
52812
Gnomad4 NFE exome
AF:
AC:
11
AN:
1109372
Gnomad4 Remaining exome
AF:
AC:
0
AN:
60080
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: 21
Find out detailed SpliceAI scores and Pangolin per-transcript scores at